Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

2.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for minimized-bias profiling of liver and visceral adipose tissue in mice using integrated single-nucleus RNA sequencing.

STAR protocols·2026
Same author

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

Nature medicine·2026
Same author

Hierarchical endpoints and win statistics for geromedicine trials.

Nature aging·2026
Same author

Cell stress and death liberate the autophagy-inhibitory tissue stress hormone DBI/ACBP into the circulation.

Autophagy·2026
Same author

Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.

Journal for immunotherapy of cancer·2026
Same author

Cell death-induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation.

Cell death and differentiation·2026

Related Experiment Video

Updated: Jul 21, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.3K

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.

Julie Le Naour1,2,3, Léa Montégut1,2,3, Yuhong Pan1,2,4

  • 1Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.

Oncoimmunology
|July 26, 2023
PubMed
Summary

Defective Formyl peptide receptor-1 (FPR1) signaling in myeloid cells impairs anti-tumor immunity, increasing susceptibility to colorectal cancer and colitis in mice. This highlights FPR1

Keywords:
Bone marrow-derived dendritic cellschemotaxisimmunogenic chemotherapyimmunosurveillancetumor microenvironment

More Related Videos

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

111.9K
Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
11:10

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation

Published on: July 6, 2022

2.3K

Related Experiment Videos

Last Updated: Jul 21, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.3K
The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

111.9K
Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
11:10

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation

Published on: July 6, 2022

2.3K

Area of Science:

  • Immunology
  • Oncology
  • Gastroenterology

Background:

  • Formyl peptide receptor-1 (FPR1) is a myeloid cell receptor involved in immune responses.
  • A loss-of-function polymorphism in FPR1 is linked to poor treatment outcomes and accelerated carcinogenesis in colorectal cancer (CRC).
  • The role of FPR1 in intestinal tumorigenesis and inflammatory bowel disease remains incompletely understood.

Purpose of the Study:

  • To investigate the role of Formyl peptide receptor-1 (FPR1) in colorectal cancer (CRC) development and progression.
  • To determine the impact of FPR1 deficiency on innate immune cell function and susceptibility to chemically induced colitis and oncogenesis.

Main Methods:

  • Utilized Fpr1 knockout (Fpr1-/-) mice and wild-type littermate controls.
  • Assessed dendritic cell migration in response to chemotherapy-treated CRC cells.
  • Induced chronic ulcerative colitis and colorectal oncogenesis using azoxymethane and dextran sodium sulfate in Fpr1-/- mice.
  • Investigated the effect of pharmacological FPR1 inhibition (cyclosporin H) and the anti-inflammatory drug sulindac in ApcMin mice.

Main Results:

  • Dendritic cells from Fpr1-/- mice showed reduced migration towards chemotherapy-treated CRC cells.
  • Fpr1-/- mice exhibited increased susceptibility to azoxymethane/dextran sodium sulfate-induced colitis and colorectal oncogenesis.
  • Pharmacological inhibition of FPR1 tended to promote intestinal tumorigenesis in ApcMin mice, an effect reversed by sulindac.

Conclusions:

  • Defective FPR1 signaling exacerbates intestinal tumorigenesis, likely by impairing innate inflammatory and immune responses.
  • FPR1 plays a critical role in host defense against colitis and colorectal cancer development.
  • Targeting FPR1 may offer therapeutic strategies for colorectal cancer and inflammatory bowel diseases.